0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Tests for Alzheimer's Diagnosis Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-14X18103
Home | Market Reports | Health| Aging & Geriatrics
Global Blood Tests for Alzheimer s Diagnosis Market Research Report 2024
BUY CHAPTERS

Global Blood Tests for Alzheimer's Diagnosis Market Research Report 2026

Code: QYRE-Auto-14X18103
Report
2026-02-11
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Tests for Alzheimer's Diagnosis Market

The global Blood Tests for Alzheimer's Diagnosis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Blood tests for Alzheimer's diagnosis are emerging as a promising tool for early detection and monitoring of the disease. These tests aim to identify biomarkers associated with Alzheimer's, such as amyloid-beta and tau proteins, which are indicators of the characteristic plaques and tangles in the brain. Advances in technology have made it possible to measure these proteins with high sensitivity and specificity in the blood. This non-invasive approach offers a more accessible, cost-effective, and less burdensome alternative to traditional methods like cerebrospinal fluid analysis and neuroimaging. Blood tests can aid in early diagnosis, potentially leading to earlier intervention and better management of Alzheimer's disease.
The North American market for Blood Tests for Alzheimer's Diagnosis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Blood Tests for Alzheimer's Diagnosis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Blood Tests for Alzheimer's Diagnosis in Clinical Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Blood Tests for Alzheimer's Diagnosis include Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Blood Tests for Alzheimer's Diagnosis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Tests for Alzheimer's Diagnosis. The Blood Tests for Alzheimer's Diagnosis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood Tests for Alzheimer's Diagnosis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood Tests for Alzheimer's Diagnosis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Blood Tests for Alzheimer's Diagnosis Market Report

Report Metric Details
Report Name Blood Tests for Alzheimer's Diagnosis Market
Segment by Type
  • Single Molecule Immunoassay Array Analysis
  • Chemiluminescence Method
  • Fluorescence PCR Method
  • Others
Segment by Application
  • Clinical Diagnosis
  • Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, KingMed Diagnostics, Hoyotek
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Blood Tests for Alzheimer's Diagnosis companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Blood Tests for Alzheimer's Diagnosis Market report?

Ans: The main players in the Blood Tests for Alzheimer's Diagnosis Market are Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, KingMed Diagnostics, Hoyotek

What are the Application segmentation covered in the Blood Tests for Alzheimer's Diagnosis Market report?

Ans: The Applications covered in the Blood Tests for Alzheimer's Diagnosis Market report are Clinical Diagnosis, Research

What are the Type segmentation covered in the Blood Tests for Alzheimer's Diagnosis Market report?

Ans: The Types covered in the Blood Tests for Alzheimer's Diagnosis Market report are Single Molecule Immunoassay Array Analysis, Chemiluminescence Method, Fluorescence PCR Method, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Single Molecule Immunoassay Array Analysis
1.2.3 Chemiluminescence Method
1.2.4 Fluorescence PCR Method
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Tests for Alzheimer's Diagnosis Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical Diagnosis
1.3.3 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Tests for Alzheimer's Diagnosis Market Perspective (2021–2032)
2.2 Global Blood Tests for Alzheimer's Diagnosis Growth Trends by Region
2.2.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Blood Tests for Alzheimer's Diagnosis Historic Market Size by Region (2021–2026)
2.2.3 Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Region (2027–2032)
2.3 Blood Tests for Alzheimer's Diagnosis Market Dynamics
2.3.1 Blood Tests for Alzheimer's Diagnosis Industry Trends
2.3.2 Blood Tests for Alzheimer's Diagnosis Market Drivers
2.3.3 Blood Tests for Alzheimer's Diagnosis Market Challenges
2.3.4 Blood Tests for Alzheimer's Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Tests for Alzheimer's Diagnosis Players by Revenue
3.1.1 Global Top Blood Tests for Alzheimer's Diagnosis Players by Revenue (2021–2026)
3.1.2 Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Players (2021–2026)
3.2 Global Top Blood Tests for Alzheimer's Diagnosis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Blood Tests for Alzheimer's Diagnosis Revenue
3.4 Global Blood Tests for Alzheimer's Diagnosis Market Concentration Ratio
3.4.1 Global Blood Tests for Alzheimer's Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Tests for Alzheimer's Diagnosis Revenue in 2025
3.5 Global Key Players of Blood Tests for Alzheimer's Diagnosis Head Offices and Areas Served
3.6 Global Key Players of Blood Tests for Alzheimer's Diagnosis, Products and Applications
3.7 Global Key Players of Blood Tests for Alzheimer's Diagnosis, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Blood Tests for Alzheimer's Diagnosis Breakdown Data by Type
4.1 Global Blood Tests for Alzheimer's Diagnosis Historic Market Size by Type (2021–2026)
4.2 Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Type (2027–2032)
5 Blood Tests for Alzheimer's Diagnosis Breakdown Data by Application
5.1 Global Blood Tests for Alzheimer's Diagnosis Historic Market Size by Application (2021–2026)
5.2 Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Blood Tests for Alzheimer's Diagnosis Market Size (2021–2032)
6.2 North America Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021–2026)
6.4 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Tests for Alzheimer's Diagnosis Market Size (2021–2032)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021–2026)
7.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size (2021–2032)
8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021–2026)
8.4 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Blood Tests for Alzheimer's Diagnosis Market Size (2021–2032)
9.2 Latin America Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021–2026)
9.4 Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size (2021–2032)
10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (2021–2026)
10.4 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Blood Tests for Alzheimer's Diagnosis Introduction
11.1.4 Roche Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Quanterix
11.2.1 Quanterix Company Details
11.2.2 Quanterix Business Overview
11.2.3 Quanterix Blood Tests for Alzheimer's Diagnosis Introduction
11.2.4 Quanterix Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.2.5 Quanterix Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Introduction
11.3.4 Quest Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.3.5 Quest Diagnostics Recent Development
11.4 C₂N Diagnostics
11.4.1 C₂N Diagnostics Company Details
11.4.2 C₂N Diagnostics Business Overview
11.4.3 C₂N Diagnostics Blood Tests for Alzheimer's Diagnosis Introduction
11.4.4 C₂N Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.4.5 C₂N Diagnostics Recent Development
11.5 Fujirebio
11.5.1 Fujirebio Company Details
11.5.2 Fujirebio Business Overview
11.5.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Introduction
11.5.4 Fujirebio Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.5.5 Fujirebio Recent Development
11.6 Diadem
11.6.1 Diadem Company Details
11.6.2 Diadem Business Overview
11.6.3 Diadem Blood Tests for Alzheimer's Diagnosis Introduction
11.6.4 Diadem Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.6.5 Diadem Recent Development
11.7 Labcorp
11.7.1 Labcorp Company Details
11.7.2 Labcorp Business Overview
11.7.3 Labcorp Blood Tests for Alzheimer's Diagnosis Introduction
11.7.4 Labcorp Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.7.5 Labcorp Recent Development
11.8 Neurocode
11.8.1 Neurocode Company Details
11.8.2 Neurocode Business Overview
11.8.3 Neurocode Blood Tests for Alzheimer's Diagnosis Introduction
11.8.4 Neurocode Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.8.5 Neurocode Recent Development
11.9 Cognitact
11.9.1 Cognitact Company Details
11.9.2 Cognitact Business Overview
11.9.3 Cognitact Blood Tests for Alzheimer's Diagnosis Introduction
11.9.4 Cognitact Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.9.5 Cognitact Recent Development
11.10 Vazyme International
11.10.1 Vazyme International Company Details
11.10.2 Vazyme International Business Overview
11.10.3 Vazyme International Blood Tests for Alzheimer's Diagnosis Introduction
11.10.4 Vazyme International Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.10.5 Vazyme International Recent Development
11.11 KingMed Diagnostics
11.11.1 KingMed Diagnostics Company Details
11.11.2 KingMed Diagnostics Business Overview
11.11.3 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Introduction
11.11.4 KingMed Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.11.5 KingMed Diagnostics Recent Development
11.12 Hoyotek
11.12.1 Hoyotek Company Details
11.12.2 Hoyotek Business Overview
11.12.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Introduction
11.12.4 Hoyotek Revenue in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
11.12.5 Hoyotek Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Single Molecule Immunoassay Array Analysis
 Table 3. Key Players of Chemiluminescence Method
 Table 4. Key Players of Fluorescence PCR Method
 Table 5. Key Players of Others
 Table 6. Global Blood Tests for Alzheimer's Diagnosis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Blood Tests for Alzheimer's Diagnosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Blood Tests for Alzheimer's Diagnosis Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Blood Tests for Alzheimer's Diagnosis Market Share by Region (2021–2026)
 Table 10. Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Blood Tests for Alzheimer's Diagnosis Market Share by Region (2027–2032)
 Table 12. Blood Tests for Alzheimer's Diagnosis Market Trends
 Table 13. Blood Tests for Alzheimer's Diagnosis Market Drivers
 Table 14. Blood Tests for Alzheimer's Diagnosis Market Challenges
 Table 15. Blood Tests for Alzheimer's Diagnosis Market Restraints
 Table 16. Global Blood Tests for Alzheimer's Diagnosis Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Blood Tests for Alzheimer's Diagnosis Market Share by Players (2021–2026)
 Table 18. Global Top Blood Tests for Alzheimer's Diagnosis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Blood Tests for Alzheimer's Diagnosis Revenue, 2025
 Table 19. Ranking of Global Top Blood Tests for Alzheimer's Diagnosis Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Blood Tests for Alzheimer's Diagnosis Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Blood Tests for Alzheimer's Diagnosis, Headquarters and Area Served
 Table 22. Global Key Players of Blood Tests for Alzheimer's Diagnosis, Products and Applications
 Table 23. Global Key Players of Blood Tests for Alzheimer's Diagnosis, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Blood Tests for Alzheimer's Diagnosis Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Type (2021–2026)
 Table 27. Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Type (2027–2032)
 Table 29. Global Blood Tests for Alzheimer's Diagnosis Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Application (2021–2026)
 Table 31. Global Blood Tests for Alzheimer's Diagnosis Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Application (2027–2032)
 Table 33. North America Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 48. Roche Company Details
 Table 49. Roche Business Overview
 Table 50. Roche Blood Tests for Alzheimer's Diagnosis Product
 Table 51. Roche Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 52. Roche Recent Development
 Table 53. Quanterix Company Details
 Table 54. Quanterix Business Overview
 Table 55. Quanterix Blood Tests for Alzheimer's Diagnosis Product
 Table 56. Quanterix Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 57. Quanterix Recent Development
 Table 58. Quest Diagnostics Company Details
 Table 59. Quest Diagnostics Business Overview
 Table 60. Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Product
 Table 61. Quest Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 62. Quest Diagnostics Recent Development
 Table 63. C₂N Diagnostics Company Details
 Table 64. C₂N Diagnostics Business Overview
 Table 65. C₂N Diagnostics Blood Tests for Alzheimer's Diagnosis Product
 Table 66. C₂N Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 67. C₂N Diagnostics Recent Development
 Table 68. Fujirebio Company Details
 Table 69. Fujirebio Business Overview
 Table 70. Fujirebio Blood Tests for Alzheimer's Diagnosis Product
 Table 71. Fujirebio Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 72. Fujirebio Recent Development
 Table 73. Diadem Company Details
 Table 74. Diadem Business Overview
 Table 75. Diadem Blood Tests for Alzheimer's Diagnosis Product
 Table 76. Diadem Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 77. Diadem Recent Development
 Table 78. Labcorp Company Details
 Table 79. Labcorp Business Overview
 Table 80. Labcorp Blood Tests for Alzheimer's Diagnosis Product
 Table 81. Labcorp Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 82. Labcorp Recent Development
 Table 83. Neurocode Company Details
 Table 84. Neurocode Business Overview
 Table 85. Neurocode Blood Tests for Alzheimer's Diagnosis Product
 Table 86. Neurocode Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 87. Neurocode Recent Development
 Table 88. Cognitact Company Details
 Table 89. Cognitact Business Overview
 Table 90. Cognitact Blood Tests for Alzheimer's Diagnosis Product
 Table 91. Cognitact Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 92. Cognitact Recent Development
 Table 93. Vazyme International Company Details
 Table 94. Vazyme International Business Overview
 Table 95. Vazyme International Blood Tests for Alzheimer's Diagnosis Product
 Table 96. Vazyme International Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 97. Vazyme International Recent Development
 Table 98. KingMed Diagnostics Company Details
 Table 99. KingMed Diagnostics Business Overview
 Table 100. KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Product
 Table 101. KingMed Diagnostics Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 102. KingMed Diagnostics Recent Development
 Table 103. Hoyotek Company Details
 Table 104. Hoyotek Business Overview
 Table 105. Hoyotek Blood Tests for Alzheimer's Diagnosis Product
 Table 106. Hoyotek Revenue in Blood Tests for Alzheimer's Diagnosis Business (US$ Million), 2021–2026
 Table 107. Hoyotek Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Blood Tests for Alzheimer's Diagnosis Picture
 Figure 2. Global Blood Tests for Alzheimer's Diagnosis Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Blood Tests for Alzheimer's Diagnosis Market Share by Type: 2025 vs 2032
 Figure 4. Single Molecule Immunoassay Array Analysis Features
 Figure 5. Chemiluminescence Method Features
 Figure 6. Fluorescence PCR Method Features
 Figure 7. Others Features
 Figure 8. Global Blood Tests for Alzheimer's Diagnosis Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Blood Tests for Alzheimer's Diagnosis Market Share by Application: 2025 vs 2032
 Figure 10. Clinical Diagnosis Case Studies
 Figure 11. Research Case Studies
 Figure 12. Blood Tests for Alzheimer's Diagnosis Report Years Considered
 Figure 13. Global Blood Tests for Alzheimer's Diagnosis Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Blood Tests for Alzheimer's Diagnosis Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Blood Tests for Alzheimer's Diagnosis Market Share by Region: 2025 vs 2032
 Figure 16. Global Blood Tests for Alzheimer's Diagnosis Market Share by Players in 2025
 Figure 17. Global Blood Tests for Alzheimer's Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Blood Tests for Alzheimer's Diagnosis Revenue in 2025
 Figure 19. North America Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Blood Tests for Alzheimer's Diagnosis Market Share by Country (2021–2032)
 Figure 21. United States Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Blood Tests for Alzheimer's Diagnosis Market Share by Country (2021–2032)
 Figure 25. Germany Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Share by Region (2021–2032)
 Figure 33. China Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Blood Tests for Alzheimer's Diagnosis Market Share by Country (2021–2032)
 Figure 41. Mexico Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Share by Country (2021–2032)
 Figure 45. Israel Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Blood Tests for Alzheimer's Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Roche Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 49. Quanterix Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 50. Quest Diagnostics Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 51. C₂N Diagnostics Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 52. Fujirebio Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 53. Diadem Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 54. Labcorp Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 55. Neurocode Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 56. Cognitact Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 57. Vazyme International Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 58. KingMed Diagnostics Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 59. Hoyotek Revenue Growth Rate in Blood Tests for Alzheimer's Diagnosis Business (2021–2026)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS